期刊文献+

178例小儿肺炎分离菌分布和耐药性分析 被引量:5

Distribution and antibiotic resistance of pathogens from 178 cases with pneumonia
下载PDF
导出
摘要 目的了解小儿肺炎病原菌谱及耐药性.方法对2003~2004年178例小儿肺炎的痰标本进行细菌学培养,测定药物敏感性.结果分离菌中,以革兰阴性菌居首位,占58.51%.肺炎克雷伯菌和大肠埃希菌为主要菌种,对亚胺培南、美罗培南的耐药性最低;其次为革兰阳性菌,占40.43%,以金黄色葡萄球菌为主,耐甲氧西林的葡萄球菌为57.1%,对万古霉素、替考拉宁最敏感.结论小儿肺炎病原菌以革兰阴性菌为主,并且出现多重耐药.临床上应避免盲目经验性用药,减少或减缓细菌耐药的发生. Objective To investigate the characteristics of bacterial distribution and drug-resistance among 128 cases with pneumonia in our hospital from July 2003 to. June 2004. Methods Total of 178 cases sputum samples were cultured and isolated. Antibiotic-resistance tests were performed using automated microbial analysis system VITEK-32. Results The main stains were Gram-negative bacilli with the rate of 58.5%. Klebsiella pneumoniae and Escherifia coli were the main stains of them. Their drug-resistance to imipenem was the lowest. The next strains were Gram-positive bacilli with the rate of 40.4%. Staphylococcus was the main one in the isolated Grampositive bacilli. The isolation rate of MRSA was 57. 1%. Vancomycin was the most sensitive for Grampositive bacilli. Conclusion The major causeof pneumonia might be Gram-egative bacteria with multidrug-resistance. In order to reduce theproduction of drug-resistance, antibiotics shouldn't be used by experience.
出处 《中国微生态学杂志》 CAS CSCD 2005年第6期458-459,共2页 Chinese Journal of Microecology
关键词 肺炎 小儿 病原菌 耐药性 Pneumonia,child Bacterial distribution Drug-resistance
  • 相关文献

参考文献8

二级参考文献38

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2[2]Stoward C D,Wallaoo D,Hubort S K,et al.Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE Laboratories [J].Diagn Microbiol Infect Dis, 2000, 38(1):59
  • 3[3]Wu T L,Siu L K,Su L H,et al.Outer membrane protein change combined with CO- existing TEM- 1 and SHV- 1 beta- lactamases lead to false identification of ESBL- producing Klebsiella pneumoniae [J].J Antimicrob Chemother, 2001, 47(16):755
  • 4[4]Pfaller M A,Acar J,Jones R N,et al.Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program[J].Clin Infect Dis, 2001, 32(Suppl 2):156
  • 5[5]Lzutenbach E,Patel J B,Bilker W B,et al.Extended- spectrum beta- lactamase- producing Escherichia coli and Klebsiella pneumoniae:risk factors for infection and impact of resistance on outcomes[J].Clin Infect Dis, 2001,32(8):1162
  • 6[6]Oplustil C P,Nunes R,Mendes C.Multicenter evaluation of resistance patterns of Klebsiella pneumoniae,Escherichia coli,Salmonella spp and Shigella spp isolated from clinical specimens in Brazil:RESISTNET surv eillance program [J].Braz J Infect Dis, 2001,5(1):8
  • 7[1]Mendes C,Hsiung A,Kiffor C,et al.Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil:MYSTIC Antimicrobial Surveillance Program [J].Braz J Infect Dis, 2000, 4(5):236
  • 8Itokazu G S, Quinn J P, Bell-Dixon C, et al. Antimicroblal resistance rates among aerobic gram-negative bacilli recovered from patients in intensive-care units: evaluation of a national postmarketing surveillance program [J]. Clin Infect Dis. 1996,23 : 779.
  • 9Jarvis W R, Martone W J. Predominant pathogens in hospital infections [J]. J Antimicrob Chemother, 1992, 29 (Suppl A):19.
  • 10Wekthagen G F. Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudornonas aeruginasa: novel developments and clinical impact [J]. Antimicrob Agents Chemother, 2003,47 (8) ; 2385.

共引文献658

同被引文献19

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部